Clinical Trial Update: Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating sulodexide for reducing albuminuria in Chinese patients with type 2 diabetes and diabetic nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Sulodexide (sulodexide)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Diabetic Nephropathy, Albuminuria | Phase 4 | Status: UNKNOWN